Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment

被引:0
|
作者
Paulo Roberto Barbosa Evora
机构
[1] University of São Paulo,Department of Surgery and Anatomy (Division of Cardiothoracic Surgery); Ribeirão Preto School of Medicine
来源
Critical Care | / 22卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment
    Barbosa Evora, Paulo Roberto
    [J]. CRITICAL CARE, 2018, 22
  • [2] Inhibition of soluble guanylate cyclase by ODQ
    Zhao, YD
    Brandish, PE
    Di Valentin, M
    Schelvis, JPM
    Babcock, GT
    Marletta, MA
    [J]. BIOCHEMISTRY, 2000, 39 (35) : 10848 - 10854
  • [3] TESTICULAR GUANYLATE CYCLASE - CORRELATION BETWEEN TISSUE CGMP LEVELS AND SOLUBLE GUANYLATE CYCLASE ACTIVITY (GCA)
    SPRUILL, WA
    STEINER, AL
    EARP, HS
    [J]. FEDERATION PROCEEDINGS, 1977, 36 (03) : 347 - 347
  • [4] Altered cGMP content and activity of soluble guanylate cyclase in liver disease
    Corbalan, R
    Montoliu, C
    Minana, MD
    Del Olmo, J
    Serra, M
    Aparisi, L
    Rodrigo, J
    Felipo, V
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 210 - 210
  • [5] Soluble Guanylate Cyclase Generation of cGMP Regulates Migration of MGE Neurons
    Mandal, Shyamali
    Stanco, Amelia
    Buys, Emmanuel S.
    Enikolopov, Grigori
    Rubenstein, John L. R.
    [J]. JOURNAL OF NEUROSCIENCE, 2013, 33 (43): : 16897 - 16914
  • [6] Effects of the NO/soluble guanylate cyclase/cGMP system on the functions of human platelets
    Makhoul, Stephanie
    Walter, Elena
    Pagel, Oliver
    Walter, Ulrich
    Sickmann, Albert
    Gambaryan, Stepan
    Smolenski, Albert
    Zahedi, Rene P.
    Jurk, Kerstin
    [J]. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2018, 76 : 71 - 80
  • [7] Guanylate cyclase inhibition by methylene blue as an option in the treatment of vasoplegia after a severe burn. A medical hypothesis
    Farina Junior, Jayme A.
    Celotto, Andrea Carla
    da Silva, Marcelo Felix
    Evora, Paulo Roberto B.
    [J]. MEDICAL SCIENCE MONITOR, 2012, 18 (05): : HY13 - HY17
  • [8] The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase
    Benza, Raymond L.
    Gruenig, Ekkehard
    Sandner, Peter
    Stasch, Johannes -Peter
    Simonneau, Gerald
    [J]. EUROPEAN RESPIRATORY REVIEW, 2024, 33 (171):
  • [9] INHIBITION OF SOLUBLE GUANYLATE-CYCLASE ACTIVITY BY CITRATE
    KARCZEWSKI, P
    KRAUSE, EG
    [J]. ACTA BIOLOGICA ET MEDICA GERMANICA, 1982, 41 (06) : 503 - 508
  • [10] Enhancing cGMP in experimental progressive renal fibrosis:: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition
    Wang, YR
    Krämer, S
    Loof, T
    Martini, S
    Kron, S
    Kawachi, H
    Shimizu, F
    Neumayer, HH
    Peters, H
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (01) : F167 - F176